惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园 - Franky
雷峰网
雷峰网
The Cloudflare Blog
WordPress大学
WordPress大学
博客园 - 聂微东
人人都是产品经理
人人都是产品经理
IT之家
IT之家
V
V2EX
博客园 - 司徒正美
小众软件
小众软件
博客园_首页
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
酷 壳 – CoolShell
酷 壳 – CoolShell
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Hugging Face - Blog
Hugging Face - Blog
T
Tailwind CSS Blog
Last Week in AI
Last Week in AI
Jina AI
Jina AI
博客园 - 叶小钗
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
阮一峰的网络日志
阮一峰的网络日志
爱范儿
爱范儿

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare...
SA Transcripts · 2026-06-04 · via All Articles on Seeking Alpha

Pfizer Inc. (PFE) Jefferies Global Healthcare Conference 2026 June 3, 2026 2:00 PM EDT

Company Participants

Albert Bourla - Chairman of the Board & CEO

Conference Call Participants

Richard Handler - Jefferies LLC

Presentation

Richard Handler
Jefferies LLC

Okay, everybody. It is my treat. I'm Rich Handler, CEO of Jefferies. I get the pleasure of interviewing my good friend, Albert Bourla, CEO of Pfizer.

Before we get going, the last time I interviewed Albert, and I was talking with him backstage, it was right in the heat of COVID when no one knew what was going to happen. And I had -- at the time, I think we had about 5,000 Jefferies employees on the Zoom. And quite honestly, I was -- I can't convey to you enough the calming, the sense of hope, the sense of purpose and the sense of strategy that you gave our firm at that point in time. So before we start, I want to give Albert and his entire company a big round of applause.

Question-and-Answer Session

Richard Handler
Jefferies LLC

Give us just a little bit of you growing up and a little bit about your background so people know who you are. And it's a pretty interesting background.

Albert Bourla
Chairman of the Board & CEO

I'm Greek. I used to say I'm Greek by birth, American by choice. I studied in Greece. I studied veterinary science. I did a PhD. All I wanted was to stay in academia to become a professor. Pfizer in Greece had an animal health group at the time, now it's Zoetis, that they were keen to hire me. They put an offer I couldn't resist. I said that I will go sabbatical a year or 2, and then I will go back to academia. But then once I joined Pfizer, I liked so much the energy of the private